Cargando…
Personalizing treatment in end-stage kidney disease: deciding between haemodiafiltration and haemodialysis based on individualized treatment effect prediction
BACKGROUND: Previous studies suggest that haemodiafiltration reduces mortality compared with haemodialysis in patients with end-stage kidney disease (ESKD), but the controversy surrounding its benefits remains and it is unclear to what extent individual patients benefit from haemodiafiltration. This...
Autores principales: | van Kruijsdijk, Rob C M, Vernooij, Robin W M, Bots, Michiel L, Peters, Sanne A E, Dorresteijn, Jannick A N, Visseren, Frank L J, Blankestijn, Peter J, Debray, Thomas P A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9494541/ https://www.ncbi.nlm.nih.gov/pubmed/36158156 http://dx.doi.org/10.1093/ckj/sfac153 |
Ejemplares similares
-
Benefits and harms of high-dose haemodiafiltration versus high-flux haemodialysis: the comparison of high-dose haemodiafiltration with high-flux haemodialysis (CONVINCE) trial protocol
por: Blankestijn, Peter J, et al.
Publicado: (2020) -
CONVINCE in the context of existing evidence on haemodiafiltration
por: Vernooij, Robin W M, et al.
Publicado: (2022) -
Clinical evidence on haemodiafiltration
por: Blankestijn, Peter J, et al.
Publicado: (2018) -
The probability of receiving a kidney transplantation in end-stage kidney disease patients who are treated with haemodiafiltration or haemodialysis: a pooled individual participant data from four randomised controlled trials
por: Vernooij, Robin W. M., et al.
Publicado: (2021) -
The effect of natriuretic C-type peptide and its change over time on mortality in patients on haemodialysis or haemodiafiltration
por: de Roij van Zuijdewijn, Camiel L M, et al.
Publicado: (2019)